This intersection between breast cancer and cardiovascular disease highlights the complex role of TGF-β in both tumor progression and heart tissue damage, making it a potential therapeutic target for modulating tumor growth while also addressing cardiovascular complications. Here, TGFB1 is linked to breast carcinoma.